🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› USA
Clinical trial register · United States · industry-sponsored

Industry-sponsored studies with a US investigative site

Every industry-sponsored study on the ClinicalTrials.gov registry that lists a US site and is open, about to open, active-but-closed, or enrolling by invitation. This deliberately excludes academic and other non-industry sponsors — the full US registry across all sponsors runs to over 22,000 recruiting studies alone.

Download CSV
Source: ClinicalTrials.gov. Complete coverage of the industry-sponsored slice — all 9112 matching records are in this view (non-industry sponsors are out of scope by design, not truncated). Synced 23 Sep 2026, 03:16 UTC
9112
Studies in scope
industry-sponsored, all four open statuses
4950
Recruiting now
open to new participants
2202
Lead sponsors
across recruiting studies
Top states
California 5295 Florida 4397 Illinois 2479 Georgia 2346 Arizona 2231
Narrow the register
Recruitment status
Phase
Lead sponsor
AstraZeneca299 Novartis Pharmaceuticals202 Eli Lilly and Company190 Merck Sharp & Dohme LLC183 AbbVie172
State
California5295 Florida4397 Illinois2479 Georgia2346 Arizona2231
All 51 states
Target enrolment
to
9112 of 9112 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
US states
Start
Not yet open
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
NCT07607327AML (Acute Myelogenous Leukemia), MDS (Myelodysplastic Syndrome), CMML
CareDx
Observational
400
California
2026-08-31
Recruiting
Efficacy, Safety, and Tolerability of Encaleret in Participants With Chronic Hypoparathyroidism
NCT07805356Hypoparathyroidism, Chronic Hypoparathyroidism
Calcilytix Therapeutics, Inc., a BridgeBio company
Phase 3
160
Nevada, North Carolina, Texas
2026-08-31
Active, closed
Clinical Investigation of Eye C Better's Photobionic Intraocular Pressure Biomonitor Tonometer
NCT07762053Elevated Intraocular Pressure (IOP)
EyeCBetter Corporation
Not applicable
15
California
2026-08-31
Not yet open
Clinical Assessment of the Safety and Efficacy of Flaus Electric Flosser on Plaque and Gingivitis Compared to a Manual Toothbrush
NCT07805148Gingivitis, Gingival Bleeding, Dental Plaque
Flaus, Inc
Not applicable
80
Indiana
2026-08-31
Recruiting
A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
NCT07680764Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 2
160
Georgia, Kentucky, Maryland, Mississippi, Nebraska, New York, Texas, Wisconsin
2026-08-31
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
NCT07743463Obesity, Overweight, Chronic Weight Management
Ascletis Pharma (China) Co., Limited
Phase 3
3,003
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Idaho
2026-08-31
Recruiting
A Study to Investigate the Safety and Efficacy of Efimosfermin Alfa Compared With Placebo in Adult Participants With Alcohol-related Liver Disease (ALD)
NCT07791043Liver Diseases, Alcoholic
GlaxoSmithKline
Phase 2
274
Kansas, Texas
2026-08-31
Not yet open
An Observational Study to Learn How Mirena and Other Progestogen Treatments Are Used for Endometrial Protection in Women 40+ With a Uterus in the United States Receiving Estrogen Therapy, and Their Respective Health Outcomes
NCT07795606Estrogen Therapy
Bayer
Observational
456,000
Michigan, Minnesota
2026-08-31
By invitation
Truway Whole-Body Digital Twin and Physiologic Resilience Study (TRU-OMNIBODY)
NCT07805044PHYSIOLOGICAL PHENOMENA, Homeostasis, Physical Functional Performance, Cardiorespiratory Fitness
Truway Health, Inc.
Observational
450
New York
2026-08-31
By invitation
Federated Learning for Point-of-Care Cardiac Ultrasound
NCT07800962Ventricular Dysfunction, Left, Ventricular Function, Left, Echocardiography, Ultrasonography
Truway Health, Inc.
Observational
3,000
New York
2026-08-31
Not yet open
Study to Evaluate the Safety and Effectiveness of ELEVIDYS in Participants With Duchenne Muscular Dystrophy Treated in a Post-Marketing Setting
NCT07542314Duchenne Muscular Dystrophy
Sarepta Therapeutics, Inc.
Phase 4
20
Texas
2026-08-31
Recruiting
Study of Safety and PK of AZD0543 in Healthy Adults
NCT07824622Human Metapneumovirus Infection
AstraZeneca
Phase 1
144
California, Florida
2026-08-31
Recruiting
A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults
NCT07768345Respiratory Syncytial Virus (RSV)
Pfizer
Phase 3
440
California, Georgia, New York
2026-08-31
Active, closed
A Clinical Trial of Enlicitide (MK-0616) Formulations in Healthy Participants (MK-0616-044)
NCT07776665Healthy
Merck Sharp & Dohme LLC
Phase 1
30
Nebraska
2026-08-31
Recruiting
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
NCT07816185Pulmonary Hypertension, Interstitial Lung Disease, Vascular Diseases, Cardiovascular Diseases
Pulmovant, Inc.
Phase 3
376
Florida, Kentucky, Oregon
2026-08-31
Recruiting
Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers
NCT07493304Venous Thromboembolism (VTE)
Regeneron Pharmaceuticals
Phase 3
1,600
Florida, New York, Texas
2026-08-31
Not yet open
Safety Study of Microlyte DualGuard
NCT07695688Wound Closure, Wound Care
Imbed Biosciences
Not applicable
53
Arizona, District of Columbia, Louisiana
2026-08-30
Recruiting
PULmonary Stimulation for Asthma Relief
NCT07709754Moderate to Severe Asthma
Spiro Medical, Inc.
Not applicable
30
Colorado, Florida
2026-08-30
Recruiting
Pilot Study: Feasibility and Usability of a Head-Mounted Spatial Computing Device for Intraoperative Visualization During Intraocular Surgery
NCT07825337Cataract Surgery
Eric Rosenberg
Observational
70
New York
2026-08-30
Not yet open
Comparison of ACUVUE® OASYS MAX 1-Day Multifocal and DAILIES® AquaComfort Plus® Multifocal
NCT07788521Visual Acuity
Johnson & Johnson Vision Care, Inc.
Not applicable
150
Florida, Georgia, Missouri, New York, Rhode Island, Tennessee, Texas, Virginia
2026-08-28
Not yet open
Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With Advanced or Metastatic Non-squamous EGFR-Wildtype Non-Small Cell Lung Cancer (NSCLC) With Progression on or After Platinum-Based Chemotherapy and Anti-PD-1/PD-L1 Immunotherapy
NCT07718737NSCLC (Advanced Non-small Cell Lung Cancer)
Multitude Therapeutics Inc.
Phase 2/3
512
Florida, Texas
2026-08-28
Recruiting
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
NCT07743450Obesity, Overweight, Chronic Weight Management, Type 2 Diabetes Mellitus
Ascletis Pharma (China) Co., Limited
Phase 3
1,560
Alabama, Arizona, Arkansas, California, District of Columbia, Florida, Georgia, Idaho
2026-08-28
Recruiting
Study of Zoldonrasib (RMC-9805) Plus Daraxonrasib (RMC-6236) Versus Gemcitabine and Nab-Paclitaxel as First-Line Treatment in Metastatic KRAS G12D-Mutated Pancreatic Adenocarcinoma
NCT07805954Pancreatic Cancer, Pancreatic Cancer Metastatic, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma
Revolution Medicines, Inc.
Phase 3
400
Florida
2026-08-28
Recruiting
A Study of RO7890597 in Healthy Adult Volunteers
NCT07797478Healthy Volunteers
Genentech, Inc.
Phase 1
139
Kansas
2026-08-28
Recruiting
Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
NCT07564141Platinum-Sensitive Ovarian Cancer, Ovarian Cancer
Genmab
Phase 3
688
Connecticut, Wisconsin
2026-08-28
Recruiting
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
NCT07778316Small Cell Lung Cancer
Amgen
Phase 3
400
Florida, Michigan, Nebraska
2026-08-28
Not yet open
Comparison of Four Qualia Sleep Formulations on Sleep Quality : An Open-label 4-arm Pilot Study
NCT07744971Sleep Quality
Qualia Life Sciences
Not applicable
100
California
2026-08-28
Recruiting
A Study Comparing Two Ways of Taking Olomorasib (LY3537982) in Healthy Participants
NCT07794592Healthy Volunteers
Eli Lilly and Company
Phase 1
24
Florida
2026-08-28
Recruiting
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
NCT07783802Atherosclerosis, Cardiovascular Disease, Obesity, Hypertension
Eli Lilly and Company
Phase 2
120
Alabama, Arizona, California, Florida, Georgia, Illinois, Indiana, Massachusetts
2026-08-27
Recruiting
A Study of LY4226695 in Healthy Participants
NCT07767487Healthy
Eli Lilly and Company
Phase 1
148
California
2026-08-27
Recruiting
Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)
NCT07766655Smoking Cessation
Axsome Therapeutics, Inc.
Phase 3
705
Arkansas, California, Florida, Georgia, Illinois, Indiana, Missouri, New York
2026-08-27
Recruiting
A Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20
NCT07792941Healthy
Pfizer
Phase 1
12
Connecticut
2026-08-27
Recruiting
A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004)
NCT07705555Diabetic Retinopathy, Macular Edema
Merck Sharp & Dohme LLC
Phase 3
960
California, Colorado, Florida, Maryland, New Jersey, New York, Tennessee, Texas
2026-08-27
Recruiting
Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions
NCT07654283Hepatitis B, Chronic
AusperBio Therapeutics Inc.
Phase 2
70
California, Maryland, New York, Texas
2026-08-27
Recruiting
ASsessing The REAl-world Safety & Effectiveness of Spinal Muscular Atrophy Participants Treated With Intrathecal Onasemnogene Abeparvovec-brve (OAV101B) (ITVISMA®): A U.S. Pragmatic Multicenter Study (STREAM)
NCT07448610Spinal Muscular Atrophy
Novartis Pharmaceuticals
Phase 4
36
New York
2026-08-27
Recruiting
A Study to Investigate the Efficacy and Safety of GSK5784283 (Felcorekibart) Compared With Placebo in Participants With Moderate to Very Severe COPD (PERSIST COPD-1)
NCT07780669Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline
Phase 3
624
Florida, Louisiana
2026-08-27
Recruiting
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
NCT07768371IgE-Mediated Food Allergy, Peanut Allergy, Cow Milk Allergy, Egg Allergy
Novartis Pharmaceuticals
Phase 3
576
Alabama, Arizona, Arkansas, California, Maryland, Michigan, New Jersey, New York
2026-08-27
Recruiting
A Study to Learn About the Study Medicine Called Rimegepant in Adults When Used for the Prevention of Chronic Migraine
NCT07729462Preventive Treatment of Migraine
Pfizer
Phase 3
400
California, Florida, Nebraska, Texas
2026-08-26
Recruiting
A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity
NCT07794579Overweight, Prediabetic State, Prehypertension, Obesity, Abdominal
Eli Lilly and Company
Phase 3
2,001
Alabama, Arizona, California, Connecticut, Florida, Georgia, Idaho, Illinois
2026-08-26
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465Symptomatic Genetic Dilated Cardiomyopathy (DCM)
Kardigan, Inc.
Phase 3
332
Alabama, California, District of Columbia, Florida, Illinois, Louisiana, Maryland, Massachusetts
2026-08-26
By invitation
Aspire In Vitro Maturation Study
NCT07789730Infertility, In Vitro Maturation of Oocytes, Assisted Reproduction Technologies
Inception Fertility Research Institute, LLC
Not applicable
40
Texas
2026-08-26
Not yet open
A Clinical Trial of Multiple Formulations of MK-4082 in Healthy Overweight and Obese Participants (MK-4082-007)
NCT07748351Healthy
Merck Sharp & Dohme LLC
Phase 1
48
California
2026-08-25
Not yet open
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
NCT07735637Newly Diagnosed Multiple Myeloma (NDMM)
AstraZeneca
Phase 3
750
Florida, Georgia, Illinois, Michigan, Minnesota, Ohio, Texas, Washington
2026-08-25
Recruiting
A Study Evaluating Adherence, Tolerability, and Patient Reported Outcomes of Giredestrant in Participants With ER+/HER2- Early Breast Cancer Who Are Intolerant to Adjuvant Aromatase Inhibitor Therapy (novERA Breast Cancer)
NCT07541079Early Breast Cancer
Genentech, Inc.
Phase 3
300
California, Michigan
2026-08-25
Recruiting
A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)
NCT07795814Heart Failure With Preserved Ejection Fraction
Edgewise Therapeutics, Inc.
Phase 2
90
Alabama, California, Illinois, Indiana, Kentucky, Louisiana, Maryland, Michigan
2026-08-25
Recruiting
Zanzalintinib Alone or in Combination With Pembrolizumab and Berahyaluronidase Alfa in Participants With Colorectal Cancer With Molecular Residual Disease
NCT07750158Colorectal Cancer
Exelixis
Phase 3
600
Iowa, Nebraska, New Jersey
2026-08-25
Recruiting
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
NCT07754461Type 2 Diabetes
Boehringer Ingelheim
Phase 3
600
Alabama, Arizona, Arkansas, California, Florida, Georgia, Hawaii, Idaho
2026-08-24
Not yet open
A Study to Learn About the Study Medicine Called Tilrekimig in People With Severe Asthma
NCT07772921Asthma
Pfizer
Phase 3
1,100
Texas
2026-08-24
Not yet open
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal Function
NCT07763418Kidney Failure, Chronic
Bristol-Myers Squibb
Phase 1
30
Arizona, Florida
2026-08-24
Recruiting
A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF
NCT07761117Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
AstraZeneca
Phase 3
6,950
Alabama, Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia
2026-08-24
Not yet open
A Phase I Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of AZD4144
NCT07783308Hepatic Impairment
AstraZeneca
Phase 1
30
Arizona, Florida, Texas
2026-08-24
Recruiting
A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease
NCT07737743Sjögren's Disease
Novartis Pharmaceuticals
Phase 2
344
Florida, Oklahoma, Texas
2026-08-24
Recruiting
A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus
NCT07776509Obesity or Overweight, Weight-Related Comorbidity, With/Without Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
500
California, Florida, Georgia, Illinois, Maryland, Missouri, Nevada, New Jersey
2026-08-24
Recruiting
AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
NCT07797335Type 2 Diabetes, Cardiovascular Risk
Novo Nordisk A/S
Phase 3
1,778
Alabama, Arizona, California, Florida, Georgia, Idaho, Illinois, Indiana
2026-08-24
Recruiting
A Study to Evaluate Efficacy, Safety and Tolerability of Remibrutinib in Adult Participants With Severe Chronic Pruritus of Unknown Origin (CPUO)
NCT07700056Chronic Pruritus of Unknown Origin
Novartis Pharmaceuticals
Phase 3
180
Georgia, Indiana, Ohio, Texas
2026-08-24
Recruiting
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
NCT07772492Severe Alopecia Areata
AbbVie
Phase 3
300
California, Florida, Idaho, Indiana, Nebraska, Ohio, Texas
2026-08-24
Recruiting
A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
NCT07527299Atrial Fibrillation
Biosense Webster, Inc.
Not applicable
1,070
Arizona, Arkansas, New York
2026-08-24
Not yet open
Phase 1 Study in Healthy Adults to See How Sevabertinib Changes Metformin Levels in the Body
NCT07753252Healthy Participants
Bayer
Phase 1
40
Florida
2026-08-21
Recruiting
Study of SIR2501 in Solid Tumor Patients Receiving Paclitaxel
NCT07765446Chemotherapy-induced Peripheral Neuropathy
Sironax USA, Inc.
Phase 2
18
Maryland, New Jersey
2026-08-21
By invitation
ECG-based AI Screening for Cases of Undiagnosed Moderate-to-Severe Aortic Stenosis in the Primary Care Setting
NCT07827105Aortic Stenosis
AccurKardia, Inc.
Observational
4,000
California
2026-08-21
Recruiting
M-2018-334 in Hematological Malignancies
NCT06225050Hematological Malignancies
Miltenyi Biomedicine GmbH
Not applicable
18
California
2026-08-21
Recruiting
Pedal Pump Clinical Trial on Edema V2
NCT07809516Lower Extremity Edema, Lower Extremity Edema Chronic, CHF - Congestive Heart Failure, CHF Exacerbation
Hillcrest
Not applicable
30
Oklahoma
2026-08-21
Recruiting
A Study of Romiplostim Plus Predniso(lo)ne vs. Predniso(lo)ne Alone for the Treatment of Previously Untreated Primary Immune Thrombocytopenia (ITP)
NCT07700238Primary Immune Thrombocytopenia
Amgen
Phase 3
126
California, Illinois, Virginia
2026-08-21
Recruiting
Rademikibart IV for Acute Asthma and COPD Exacerbation
NCT07705737Asthma Acute, COPD Exacerbation Acute
Connect Biopharm LLC
Phase 2
40
Florida
2026-08-21
Not yet open
Observational Study of Decentralized Urine Optical Interaction Patterns Associated With Environmental Microplastic and Nanoplastic Exposure
NCT07775495Healthy Adult Participants
Ecotera Health LLC
Observational
15
Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware
2026-08-21
Recruiting
A Randomized, Phase 2 Study of Oral BGE-102 in Participants With Center-Involved Diabetic Macular Edema
NCT07812090Diabetic Macular Edema (DME)
BioAge Labs, Inc.
Phase 2
180
Texas
2026-08-21
Not yet open
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose Administration
NCT07780383Alzheimer's Disease, Healthy Participants
Bristol-Myers Squibb
Phase 1
84
California
2026-08-21
Recruiting
A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.
NCT07753993Chronic Kidney Disease
AstraZeneca
Phase 3
7,000
Alabama, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia
2026-08-21
Recruiting
A Study to Assess Adverse Events and How Oral ABBV-932 Moves Through the Body When Given With Oral Itraconazole in Adult Participants With Bipolar Disorder
NCT07071532Bipolar Disorder
AbbVie
Phase 1
20
California, Illinois
2026-08-20
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
NCT07784270Obesity or Overweight, Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
1,500
Alabama, Arizona, Arkansas, California, Florida, Georgia, Illinois, Kansas
2026-08-20
Not yet open
Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma
NCT07700979Gastric / Gastroesophageal Junction Adenocarcinoma
Akeso
Phase 3
900
Arizona, California, Colorado, Connecticut, Massachusetts, Michigan, New York, Oregon
2026-08-20
Not yet open
Digital Behavioral Therapy to Reduce Diabetes and Liver Disease Risk
NCT07032311Type 2 Diabetes, Liver Disease
SIPPA Solutions INC
Not applicable
180
New York
2026-08-20
Recruiting
A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of ONO-6414 Administered Orally in Healthy Adult Participants and Patients With Active Ulcerative Colitis
NCT07749768Ulcerative Colitis (UC)
Ono Pharmaceutical Co., Ltd.
Phase 1
90
Florida
2026-08-20
Recruiting
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
NCT07783542Hidradenitis Suppurativa (HS)
Oruka Therapeutics, Inc.
Phase 2
200
North Carolina, Texas
2026-08-20
By invitation
Cor360: Clinician-Facing Broad-Spectrum Cardiac Phenotyping and Risk Assessment Using COR® Wearable ECG to Inform Outcomes-Oriented Care Pathways
NCT07775976Cardiovascular Diseases, Cardiovascular Diseases Risk, Cardiac Conduction System Disease, Bundle/Fascicular Abnormalities
Peerbridge Health, Inc
Observational
1,000
California, Tennessee
2026-08-20
Not yet open
GUT-FEELINGS: Using Citizen Science for Large-Scale Prebiotic Clinical Trials for Mental Health in Adults
NCT07752823Sleep Disturbance, Stress, Feeling Anxious
Holobiome, Inc.
Not applicable
1,000
California
2026-08-20
Recruiting
Relapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
NCT07686263Schizophrenia
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Phase 3
472
Arkansas, California, Florida, Georgia, Illinois, Maryland, Ohio, Oklahoma
2026-08-20
Recruiting
PheCheck™ Validation Study
NCT07551921Phenylketonuria (PKU) and Hyperphenylalaninemia
Aptatek BioSciences, Inc
Observational
60
Illinois, Massachusetts
2026-08-20
Recruiting
A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
NCT07143448Pulmonary Arterial Hypertension
35Pharma Inc
Phase 1/2
90
Florida, Rhode Island
2026-08-19
Recruiting
SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors
NCT07812805Selected Advanced Solid Tumors, Colorectal Cancer (CRC), Pancreatic Ductal Adenocarcinoma (PDAC), Biliary Tract Cancer (BTC)
SK Life Science, Inc.
Phase 1
100
Maryland, Pennsylvania
2026-08-19
Not yet open
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
NCT07783425Atopic Dermatitis
Pfizer
Phase 3
1,375
Oklahoma
2026-08-19
Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
NCT07784725Obesity or Overweight
AstraZeneca
Phase 3
2,500
Alabama, Arizona, California, Florida, Georgia, Illinois, Iowa, Michigan
2026-08-19
Recruiting
VEL-101 to Prevent Rejection After Kidney Transplantation
NCT07290777Transplantation, Kidney
Veloxis Pharmaceuticals
Phase 2
120
Texas
2026-08-18
Recruiting
Mobile Technology to Reduce Teen Substance Misuse
NCT05897164Substance Use, Substance Abuse, Suicide, Adolescent
Evidence-Based Practice Institute, Seattle, WA
Not applicable
600
Maryland, Washington
2026-08-18
Not yet open
First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors
NCT07686068Participants With Advanced Solid Tumor Malignancies
VelaVigo Bio Inc
Phase 1/2
260
Texas, Utah, Virginia
2026-08-18
Recruiting
Safety and Efficacy of Flaus Electric Flosser on Plaque and Gingivitis Compared to a Manual Toothbrush
NCT07779564Gingivitis, Gingival Bleeding, Dental Plaque
Flaus, Inc
Not applicable
80
Indiana
2026-08-18
Recruiting
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.
NCT07288489Blood Loss, Surgical, Coagulation Disorder
VarmX B.V.
Phase 3
800
Arizona, California, Colorado, Delaware, Florida, Iowa, Massachusetts, Michigan
2026-08-18
Recruiting
A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease
NCT07298421Moderately to Severely Active Crohns Disease
Hoffmann-La Roche
Phase 3
100
New York
2026-08-18
Recruiting
A Study to Test How Well BAY 3670549 Works and How Safe it is in Patients With Atrial Fibrillation
NCT07625215Atrial Fibrillation
Bayer
Phase 2
360
California, Colorado, Massachusetts, Michigan, North Carolina, Texas
2026-08-18
Recruiting
Study of NXP900 With Lorlatinib in ALK+ Lung Cancer
NCT07784959ALK Positive, ALK Positive Non-small Cell Lung Cancer, NSCLC, ALK+ Non-Small-Cell Lung Carcinoma
Nuvectis Pharma, Inc.
Phase 1
54
Virginia
2026-08-17
Recruiting
A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe Eczema
NCT07765888Atopic Dermatitis
Pfizer
Phase 3
375
California, Florida
2026-08-17
Active, closed
Real-World Effectiveness of Ritlecitinib in Alopecia Areata Patients in the US: A Retrospective Analysis Using EHR and Claims Data
NCT07821216Alopecia Areata
Pfizer
Observational
7,500
New York
2026-08-17
Not yet open
A Study of Ulonivirine (MK-8507) and Methadone in Healthy Volunteers (MK-8507-019)
NCT07595263Healthy
Merck Sharp & Dohme LLC
Phase 1
14
Alabama
2026-08-17
Recruiting
A First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of HMB-003 in Healthy Volunteers
NCT07798505Healthy Adult Participants
Hemab ApS
Phase 1
40
Texas
2026-08-17
Recruiting
Safety and Effectiveness of Sebetralstat (KVD900) for Short-Term Prophylaxis Before Procedures in People With Hereditary Angioedema (KONTROL)
NCT07654829Hereditary Angioedema
KalVista Pharmaceuticals, Ltd.
Phase 4
100
Colorado
2026-08-17
Recruiting
Pivotal Study of N-acetyl-L-leucine for CACNA1A
NCT07221292CACNA1A, Spinocerebellar Ataxia Type 6, Episodic Ataxia Type 2, Familial Hemiplegic Migraine-1
IntraBio Inc
Phase 3
60
Maryland, Massachusetts, Texas
2026-08-17
Recruiting
Agreement of Two OCT Biometers: A Pilot Study
NCT07782619Anterior Segment of Eye, Axial Length, Biometrics Measurement
Alcon Research
Observational
50
Utah
2026-08-17
Recruiting
A Study to Evaluate Mivelsiran in Adult Participants With Early-Stage Down Syndrome-Associated Alzheimer's Disease (DS-AD)
NCT07636811Down Syndrome-Associated Alzheimer's Disease (DS-AD)
Alnylam Pharmaceuticals
Phase 2
58
Florida
2026-08-17
Recruiting
A Study of LY4355756 in Healthy Participants
NCT07765498Healthy
Eli Lilly and Company
Phase 1
123
Texas
2026-08-17
Recruiting
Safety and Effectiveness of the Sphere-9™ Catheter and Affera™ Ablation System for the Treatment of Ventricular Tachycardia (Sphere VT)
NCT07585968Ventricular Tachycardia
Medtronic Cardiac Ablation Solutions
Not applicable
260
New York, North Carolina, Ohio, Texas
2026-08-17
Rows per page Showing 301–400 of 9112
Previous 2 3 4 5 6 Next
Cite this view

Priya Life Science (2026). Clinical trial register: industry-sponsored studies with a US investigative site. Derived from ClinicalTrials.gov. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-usa?page=4

Query this register directly
GET /api/trials?country=usa&status=recruiting&format=json Try it now →
→

Browse trials by condition

Advanced Solid Tumor (143) Breast Cancer (139) Obesity (123) Multiple Myeloma (109) Advanced Solid Tumors (89) Colorectal Cancer (83) Solid Tumor (81) Overweight (77) Ovarian Cancer (74) Healthy (73) Prostate Cancer (73) Heart Failure (72) Non-Small Cell Lung Cancer (70) Cancer (65) Melanoma (63)
→

Browse trials by state

California (5295) Florida (4397) Illinois (2479) Georgia (2346) Arizona (2231) New York (2126) Colorado (2066) Texas (1969) Massachusetts (1836) Michigan (1481) Alabama (1288) Connecticut (1274) Maryland (1267) Ohio (1252) Indiana (1114)
Listing here is informational and not medical advice; eligibility is determined by each study team. Compare pay for the teams running these studies in the US Pharma Salary Guide, see who's behind them in the US Company Directory, or track approvals on the FDA Approvals Tracker. For Irish, UK and EU sites, see the Ireland, UK and EU registers.